Differentiation-related expression of the Thomsen-Friedenreich glycotope in developing human lung and in lung carcinoma: Lack of association with malignancy

Cancer

Volumn 85, Issue 10, 1999, Pages 2151-2159

  Toma, Valeriu ^a   Sata, Tetsutaro ^b   Vogt, Peter ^a   Komminoth, Paul ^a   Heitz, Philipp U ^a   Roth, Jürgen ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Amaranthin; Histochemistry; Lung carcinoma; Thomsen Friedenreich glycotope

Indexed keywords

AMARANTH; DIFFERENTIATION ANTIGEN; THOMSEN FRIEDENREICH GLYCOTOPE; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CONTROLLED STUDY; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; ANTIGENS, DIFFERENTIATION; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LUNG; LUNG NEOPLASMS; PREDICTIVE VALUE OF TESTS;

EID: 0033562674     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990515)85:10<2151::AID-CNCR9>3.0.CO;2-3     Document Type: Article

References (55)

1. Hakomori SI. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989;52: 257-331.
2. Muramatsu T. Carbohydrate signals in metastasis and prognosis of human carcinomas. Glycobiology 1993;3:294-6.
3. Nilsson O. Carbohydrate antigens in human lung carcinomas. APMIS 1992;100:149-61.
4. Springer GF. T and Tn, general carcinoma autoantigens. Science 1984;224:1198-206.
5. Springer GF. T and Tn pancarcinoma markers: autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma-detection, and long-term breast carcinoma immunotherapy. Crit Rev Oncogenes 1995;6:57-85.
6. Hanisch F, Baldus S. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen. Histol Histopathol 1997;12:263-81.
7. Thomsen O. Ein vermehrungsfähiges Agens als Veränderer des isoagglutinatorischen Verhaltens der roten Blutkörperchen, eine bisher unbekannte Quelle der Fehlbestimmungen. Z Immunforsch 1927;52:85-107.
8. Friedenreich V. The Thomsen hemagglutination phenomenon. Copenhagen: Levin & Munksgaard, 1930.
9. Kim Z, Uhlenbruck G. Untersuchungen über T Antigen und T Agglutinin. Z Immunforsch 1966;130:88-99.
10. Dahlenborg K, Hultman L, Carlsson R, Jansson B. Human monoclonal antibodies specific for the tumor associated Thomsen-Friedenreich antigen. Int J Cancer 1997;70:63-71.
11. Longenecker B, Williams D, MacLean G, Selvaraj S, Surech M, Noujaim A. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers. J Natl Cancer Inst 1987;78:489-96.
12. Orntoft TF, Harving N, Langkilde NC. O-linked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen and accumulation of Tn and sialosyl-Tn antigens in carcinomas, Int J Cancer 1990;45:666-72.
13. Yuan M, Itzkowitz SH, Boland CR, Kim YD, Tomita JT, Palekar A, et al. Comparison of T antigen expression in normal, pre-malignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res 1986;46:4841-7.
14. Kaifu R, Osawa T. Syntheses of 0-β-D-galactopyranosyl-(1-3)-O-(2-acetamido-2-deoxy-α(and -β)-D-galactopyranosyl)-N-tosyl-L-serine and their interaction with D-galactose-binding proteins. Carbohydr Res 1979;69:79.
15. Lotan R, Skutelsky E, Danon D, Sharon N. The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). J Biol Chem 1975;250:8518.
16. Pereira M, Kabat E, Lotan R, Sharon N. Immunochemical studies on the specificity of the peanut (Arachis hypogaea) agglutinin. Carbohydr Res 1976;51:107.
17. Uhlenbruck G, Pardoe G, Bird G. On the specificity of lectins with a broad agglutination spectrum. II. Studies on the nature of the T-antigen and the specific receptors for the lectin of Arachis hypogaea (grand nut). Z Immunitätsforsch 1969;138:423.
18. Rinderle SJ, Goldstein IJ, Matta KL, Ratcliffe RM. Isolation and characterization of amaranthin, a lectin present in the seeds of Amaranthus caudatus, which recognizes the T-(or cryptic T) antigen. J Biol Chem 1989;264:16123-31.
19. Swamy MJ, Gupta D, Mahanta SK, Surolia A. Further characterization of the saccharide specificity of peanut (Arachis hypogaea) agglutinin. Carbohydr Res 1991;213:59-67.
20. Rinderle SJ, Goldstein IJ, Remsken EE. Physicochemical properties of amaranthin, the lectin from Amaranthus caudatus seeds. Biochemistry 1990;29:10555-61.
21. Sata T, Zuber C, Rinderle SJ, Goldstein IJ, Roth J. Expression patterns of the T antigen and the cryptic T antigen in rat fetuses: detection with the lectin Amaranthin. J Histochem Cytochem 1990;38:763-74.
22. Vaith P, Uhlenbruck G. The Thomsen agglutination phenomenon: a discovery revisited 50 years later. Z Immunitätsforsch 1978;154:1-14.
23. Fry W, Springer GF, Desai P. Lung cancer patients autoimmune responses to Thomsen-Friedenreich (T) antigen: diagnostic utility. Klin Wschr 1983;61:817-8.
24. Ichinose J, Yagawa K, M K, Hara N, Otha M. Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leucocyte adherence inhibition test. Cancer Res 1985;45:4473-7.
25. Springer GF, Murthy S, Desai P, Fry W, Tegtmeyer H, ScanIon E. Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity. Klin Wschr 1982;60:121-31.
26. Springer GF, Desai PR, Wise W, Carlstedt SC, Tegtmeyer H, Stein R. Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis. Hebermann RB, Mercer DW, editors. Immunodiagnosis of cancer. New York: Dekker, 1990:587-611.
27. Fung P, Madej M, Koganty R, Longenecker B. Active specific immunotherapy of a murine adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res 1990;50: 4308-14.
28. Livingston P. Active specific immunotherapy in the treatment of patients with cancer. Immunol Allergy Clin North Am 1991;11:401-23.
29. Longenecker BM, Reddish M, Koganty R, Mac-Lean GD. Specificity of the IgG response in mice and human breast cancer patients following immunisation against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis. Adv Exp Med Biol 1994;353:105-24.
30. MacLean GD, Reddish MA, Koganty RR, Longenecker BM. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic sTn vaccine. J Immunother 1996;19:59-68.
31. MacLean GD, Longenecker BM. Clinical significance of the Thomsen-Friedenreich antigen. Semin Cancer Biol 1991;2: 433-9.
32. Springer GF, Desai PR, Spencer BD, Tegtmeyer H, Scallon EF. T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced breast carcinoma. Cancer Detect Prev 1995;19:374-80.
33. Sata T, Zuber C, Stamm B, Heitz PU, Rinderle S, Goldstein IJ, et al. Studies on the Thomsen-Friedenreich antigen in human colon with the lectin Amaranthin. Normal and neoplastic epithelium express cryptic T antigen. Lab Invest 1992;66:175-86.
34. Cao Y, Karsten UR, Liebrich W, Haensch W, Springer GF, Schlag PM. Expression of Thomsen-Friedenreich related antigens in primary and metastatic colorectal carcinomas: a reevaluation. Cancer 1995;76:1700-8.
35. Hammar S. Common neoplasms. Dail D, Hammar S, editors. Pulmonary pathology. New York: Springer-Verlag, 1994:1123-1278.
36. Slot JW, Geuze HJ. A new method of preparing gold probes for multiple labeling cytochemistry. Eur J Cell Biol 1985;38: 87-9.
37. Lucocq J, Baschong W. Preparation of protein colloidal gold complexes in the presence of commonly used buffers. Eur J Cell Biol 1986;42:332-7.
38. The World Health Organization histological typing of lung tumors. Am J Clin Pathol 1982;77:123-36.
39. Roth J, Warhol M. Immunogold silver staining techniques for high resolution immunohistochemistry in clinical materials. Bullock G, van Velzen D, Warhol M, editors. Techniques in diagnostic pathology. London: Academic Press, 1992:2-23.
40. Cao Y, Stosiek P, Springer GF, Karsten U. Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem Cell Biol 1996;106:197-207.
41. Barr N, Taylor C, Young T, Springer GF. Are pancarcinoma T and Tn differentiation antigens? Cancer Res 1989;64:834-41.
42. Baldus SE, Hanisch FG, Kotlarek GM, Zirbes TK, Thiele J, Isenberg J, et al. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms. Cancer 1998;82:1019-27.
43. Boland CR, Chen YF, Rinderle SJ, Resau JH, Luk GD, Lynch HD, et al. The use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells. Cancer Res 1991;51:657.
44. Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, et al. Expression of Tn, sialosyl-Tn and T antigens in human colon cancer. Cancer Res 1989;49:197-204.
45. Limas C, Lange P. T antigen in normal and neoplastic urothelium. Cancer 1986;58:1236-45.
46. Campbell BJ, Finnie IA, Hounsell EF, Rhodes JM. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest 1995;95:571-6.
47. Carneiro F, Santos L, David L, Dabelsteen E, Clausen H, Sobrinhosimoes M. T (Thomsen-Friedenreich) antigen and other simple mucin-type carbohydrate antigens in precursor lesions of gastric carcinoma. Histopathology 1994;24: 105-13.
48. Sotozono MA, Okada Y, Tsuji T. The Thomsen-Friedenreich antigen-related carbohydrate antigens in human gastric intestinal metaplasia and cancer. J Histochem Cytochem 1994; 42:1575-84.
49. Therkildsen M, Mandel U, Thorn J, Christensen M, Dabelsteen E. Simple mucin-type carbohydrate antigens in major salivary glands. J Histochem Cytochem 1994;42:1251-9.
50. Philipsen E, Jorensen M, Dabelsteen E. Expression of blood group-related carbohydrate antigens in normal human pancreatic tissue. APMIS 1991;99:931-40.
51. Wolf M, Ludwig A, Fritz P, Schumacher K. Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients. Tumor Biol 1988;9:190-4.
52. Springer GF. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J Mol Med 1997; 75:594-602.
53. Itai S, Nishikata J, Takahashi N, Tanaka O, Matsubara Y, Hasegawa S, et al. Differentiation-dependent expression of I and sialyl I antigens in the developing lung of human embryos and in lung cancers. Cancer Res 1990;50:7603-11.
54. Sugiyama K, Kawai T, Nagata N, Suzuki M. Tumor-associated carbohydrate antigens in primary pulmonary adenocarcinomas and their metastases. Hum Pathol 1992;23: 900-4.
55. Miyake M, Zenita K, Tanaka O, Okada Y, Kannagi R. Stage-specific expression of SSEA-1-related antigens in the developing lung of human embryos and its relation to the distribution of these antigens in lung cancers. Cancer Res 1988; 48:7150-8.